PL3419632T3 - NR lub NMN do wzmacniania regeneracji wątroby - Google Patents

NR lub NMN do wzmacniania regeneracji wątroby

Info

Publication number
PL3419632T3
PL3419632T3 PL17757141.1T PL17757141T PL3419632T3 PL 3419632 T3 PL3419632 T3 PL 3419632T3 PL 17757141 T PL17757141 T PL 17757141T PL 3419632 T3 PL3419632 T3 PL 3419632T3
Authority
PL
Poland
Prior art keywords
nmn
liver regeneration
enhancing liver
enhancing
regeneration
Prior art date
Application number
PL17757141.1T
Other languages
English (en)
Inventor
Joseph Baur
Sarmistha MUKHEREJEE
Original Assignee
The Trustees Of The University Of Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Trustees Of The University Of Pennsylvania filed Critical The Trustees Of The University Of Pennsylvania
Publication of PL3419632T3 publication Critical patent/PL3419632T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL17757141.1T 2016-02-22 2017-02-22 NR lub NMN do wzmacniania regeneracji wątroby PL3419632T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662298139P 2016-02-22 2016-02-22
PCT/US2017/018929 WO2017147180A1 (en) 2016-02-22 2017-02-22 Methods for enhancing liver regeneration

Publications (1)

Publication Number Publication Date
PL3419632T3 true PL3419632T3 (pl) 2024-05-06

Family

ID=59685698

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17757141.1T PL3419632T3 (pl) 2016-02-22 2017-02-22 NR lub NMN do wzmacniania regeneracji wątroby

Country Status (7)

Country Link
US (2) US11103496B2 (pl)
EP (1) EP3419632B1 (pl)
JP (1) JP6727317B2 (pl)
CN (1) CN109475572A (pl)
ES (1) ES2971878T3 (pl)
PL (1) PL3419632T3 (pl)
WO (1) WO2017147180A1 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3419632T3 (pl) 2016-02-22 2024-05-06 The Trustees Of The University Of Pennsylvania NR lub NMN do wzmacniania regeneracji wątroby
WO2018170389A1 (en) * 2017-03-17 2018-09-20 Elysium Health, Inc. Nicotinamide riboside for use in treating or preventing liver damage
US20190076456A1 (en) * 2017-09-12 2019-03-14 Stephen McNERLIN Compositions and methods for liver diseases
HRP20250301T1 (hr) * 2018-03-13 2025-04-25 Nuchido Limited Pripravak koji utječe na koncentraciju nikotinamid adenin dinukleotida (nad) za ublažavanje učinaka starenja
CN110251527B (zh) * 2019-06-06 2021-06-25 泓博元生命科技(深圳)有限公司 含烟酰胺单核苷酸的组合物在抗衰老药品/保健品的应用
CN110548040A (zh) * 2019-10-17 2019-12-10 苏州大学 β-NMN在制备脓毒症器官损伤的治疗、预防药物中的应用
CN110680827A (zh) * 2019-11-05 2020-01-14 深圳市龙格生技术有限公司 一种烟酰胺核糖衍生物的注射剂药物
CN111838669B (zh) * 2020-08-07 2022-11-29 四川大学华西医院 治疗改善易损脏器的纳米组合物、制剂及制备方法和用途
AU2021403021A1 (en) * 2020-12-15 2023-07-06 Mars, Incorporated Systems and methods for identifying cancer in pets
EP4284335A1 (en) 2021-02-01 2023-12-06 RegenxBio Inc. Gene therapy for neuronal ceroid lipofuscinoses
US11376271B1 (en) * 2021-04-02 2022-07-05 Fulgent Life Inc. Methods of ameliorating the effects of alcoholic liver damage
CN114246941A (zh) * 2021-10-18 2022-03-29 广东昊邦医药健康有限责任公司 一种具有预防宿醉和解酒保肝的组合物及其应用
CN113750242A (zh) * 2021-10-28 2021-12-07 复旦大学附属中山医院 Nmn联合cd38抑制剂在制备预防或治疗阿霉素所致心脏毒性药物中的应用
US11571438B1 (en) 2022-05-23 2023-02-07 Sasan Akhavan Nutraceutical compositions to up-regulate SIRT1 and methods of use
CN115569118B (zh) * 2022-10-27 2023-05-05 泓博元生命科技(深圳)有限公司 高效提升nad+水平的微球制剂及制备工艺
CN119112849A (zh) * 2024-09-09 2024-12-13 浙江大学 异丹叶大黄素在制备防治对乙酰氨基酚诱导急性肝损伤药物中的应用
CN119548492A (zh) * 2024-11-19 2025-03-04 中国药科大学 刺桐碱在制备促进肝脏再生药物中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58126767A (ja) * 1982-01-22 1983-07-28 Ajinomoto Co Inc 肝臓病患者用栄養組成物
JPH0427317Y2 (pl) 1987-05-18 1992-06-30
CN1964627B (zh) * 2004-06-04 2011-10-19 华盛顿大学 治疗神经病变的方法和组合物
EP1877054A2 (en) 2005-03-30 2008-01-16 Sirtris Pharmaceuticals, Inc. Nicotinamide riboside and analogues thereof
US8846393B2 (en) * 2005-11-29 2014-09-30 Gamida-Cell Ltd. Methods of improving stem cell homing and engraftment
TW200918542A (en) 2007-06-20 2009-05-01 Sirtris Pharmaceuticals Inc Sirtuin modulating compounds
CA2805033A1 (en) * 2009-07-14 2011-01-20 Beth Israel Deaconess Medical Center, Inc. Methods of increasing liver proliferation
DK2670404T3 (en) 2011-02-02 2018-11-19 Univ Princeton CIRCUIT MODULATORS AS VIRUS PRODUCTION MODULATORS
US20140221319A1 (en) 2011-06-29 2014-08-07 Mayo Foundation For Medical Education And Research Small Molecule CD38 Inhibitors and Methods of Using Same
CN103565818A (zh) * 2012-07-20 2014-02-12 上海交通大学 烟酰胺腺嘌呤二核苷酸在制备防治化疗药物盐酸阿霉素诱导的肝脏损伤药物中的应用
US20160287621A1 (en) * 2013-11-06 2016-10-06 President And Fellows Of Harvard College Biological production of nad precursors and analogs
PL3419632T3 (pl) 2016-02-22 2024-05-06 The Trustees Of The University Of Pennsylvania NR lub NMN do wzmacniania regeneracji wątroby

Also Published As

Publication number Publication date
US11103496B2 (en) 2021-08-31
EP3419632B1 (en) 2023-12-20
ES2971878T3 (es) 2024-06-10
EP3419632A1 (en) 2019-01-02
JP2019505559A (ja) 2019-02-28
US20190099409A1 (en) 2019-04-04
JP6727317B2 (ja) 2020-07-22
US11559522B2 (en) 2023-01-24
CN109475572A (zh) 2019-03-15
US20210346365A1 (en) 2021-11-11
EP3419632A4 (en) 2019-10-23
WO2017147180A1 (en) 2017-08-31

Similar Documents

Publication Publication Date Title
DK3478217T3 (en) Historisk scanningsreference for intraorale scanninger
AU201613875S (en) Headlamp
GB201602934D0 (en) Compounds
GB201620119D0 (en) Compounds
GB201619694D0 (en) Compounds
GB201610854D0 (en) Compounds
GB201604020D0 (en) Compounds
GB201604027D0 (en) Compounds
SI3464336T1 (sl) Spojine
IL255357A0 (en) bicyclic compounds
IL263228A (en) Benzoxaborole compounds
PL3686078T3 (pl) Pojazd szynowy
GB201613946D0 (en) Compounds
GB201608777D0 (en) Compounds
AU201613876S (en) Headlamp
GB201604022D0 (en) Compounds
GB201604030D0 (en) Compounds
GB201713217D0 (en) Compounds
GB201621520D0 (en) Compounds
GB201622362D0 (en) Compounds
GB201604029D0 (en) Compounds
GB201503926D0 (en) Compounds
GB201501115D0 (en) Compounds
GB201622365D0 (en) Compounds
GB201604031D0 (en) Compounds